| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 54.076 | 97.424 | 133.698 | 109.371 | 73.462 | 14.551 | 23.573 | 74.134 | 201.636 | 345.190 |
| Total Income - EUR | 54.076 | 106.336 | 133.710 | 109.402 | 73.476 | 14.561 | 25.101 | 74.134 | 201.987 | 345.191 |
| Total Expenses - EUR | 72.637 | 89.468 | 115.909 | 99.475 | 85.267 | 32.074 | 36.706 | 65.196 | 197.034 | 280.878 |
| Gross Profit/Loss - EUR | -18.561 | 16.869 | 17.801 | 9.927 | -11.791 | -17.513 | -11.604 | 8.938 | 4.953 | 64.313 |
| Net Profit/Loss - EUR | -20.183 | 15.805 | 16.400 | 8.833 | -12.486 | -17.657 | -11.912 | 8.196 | 3.181 | 55.734 |
| Employees | 1 | 2 | 2 | 3 | 3 | 1 | 1 | 1 | 3 | 10 |
Check the financial reports for the company - Medy & Davy Comimpex Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 30.628 | 28.515 | 0 | 0 | 9.457 | 6.269 | 0 | 1.120 | 9.655 | 35.139 |
| Current Assets | 18.200 | 30.619 | 33.070 | 49.849 | 36.450 | 14.220 | 4.754 | 21.158 | 30.585 | 44.976 |
| Inventories | 7.325 | 617 | 950 | 183 | 2.127 | -318 | 110 | 2.168 | 10.700 | 6.430 |
| Receivables | 8.106 | 8.038 | 5.779 | 6.318 | 9.930 | 11.877 | 4.122 | 18.749 | 15.555 | 32.713 |
| Cash | 2.769 | 21.965 | 26.341 | 43.347 | 24.394 | 2.661 | 522 | 241 | 4.331 | 5.833 |
| Shareholders Funds | -29.491 | 7.286 | 23.563 | 31.964 | 18.859 | 845 | -11.086 | -2.924 | 266 | 55.999 |
| Social Capital | 47 | 47 | 46 | 45 | 44 | 43 | 42 | 43 | 42 | 42 |
| Debts | 78.319 | 51.848 | 9.506 | 17.885 | 27.048 | 19.644 | 15.840 | 25.202 | 39.974 | 24.753 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4711 - 4711" | |||||||||
| CAEN Financial Year |
5610
|
|||||||||
Comments - Medy & Davy Comimpex Srl